Literature DB >> 2521788

Brain natriuretic peptide is a novel cardiac hormone.

Y Saito1, K Nakao, H Itoh, T Yamada, M Mukoyama, H Arai, K Hosoda, G Shirakami, S Suga, N Minamino.   

Abstract

Using a radioimmunoassay for brain natriuretic peptide (BNP), we have measured levels of BNP-like immunoreactivity (-LI) in extract of the porcine heart, in perfusate from the isolated porcine heart and in porcine plasma. BNP-LI was detected in the extract of the atrium, though no detectable amount of BNP-LI (more than 1 ng/g) was present in the ventricle. The BNP-LI level in the porcine atrium was 148.7 +/- 23.3 ng/g. BNP-LI was also detected in the perfusate from the heart. Basal secretory rate of BNP was 3.18 +/- 0.76 ng/min. Moreover, BNP-LI was detected in porcine plasma at the concentration of 4.2 +/- 1.3 pg/ml. Gel filtration studies showed that BNP is present in the atrium as a large molecule and is secreted into the circulation as a small molecule. The percentage of BNP-LI to atrial natriuretic peptide (ANP)-LI was almost the same among the extract, the perfusate and the plasma (2-3 percent). These results indicate that BNP is synthesized in and is secreted into the circulation from the heat in a similar fashion as ANP.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521788     DOI: 10.1016/s0006-291x(89)80056-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

1.  [Postoperative therapy using human atrial natriuretic peptide in cases of valve replacement].

Authors:  T Maeda; M Kitamura; A Kawai; M Hachida; S Aomi; M Endo; H Koyanagi; Y Sakomura; N Matsuda; H Kasanori
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-12

2.  Immunoreactive atrial and brain natriuretic peptides are co-localized in Purkinje fibres but not in the innervation of the bovine heart conduction system.

Authors:  M Hansson; S Forsgren
Journal:  Histochem J       Date:  1995-03

3.  Detection of immunoreactive atrial and brain natriuretic peptides in the equine atrium.

Authors:  H Mifune; R Richter; W G Forssmann
Journal:  Anat Embryol (Berl)       Date:  1995-08

4.  Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene.

Authors:  Y Ogawa; H Itoh; N Tamura; S Suga; T Yoshimasa; M Uehira; S Matsuda; S Shiono; H Nishimoto; K Nakao
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

5.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Authors:  M Mukoyama; K Nakao; K Hosoda; S Suga; Y Saito; Y Ogawa; G Shirakami; M Jougasaki; K Obata; H Yasue
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Molecular cloning of hamster brain and atrial natriuretic peptide cDNAs. Cardiomyopathic hamsters are useful models for brain and atrial natriuretic peptides.

Authors:  N Tamura; Y Ogawa; H Itoh; H Arai; S Suga; O Nakagawa; Y Komatsu; I Kishimoto; K Takaya; T Yoshimasa
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

7.  Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease.

Authors:  A M Richards; I G Crozier; T G Yandle; E A Espiner; H Ikram; M G Nicholls
Journal:  Br Heart J       Date:  1993-05

8.  B-type natriuretic peptide 8-32, which is produced from mature BNP 1-32 by the metalloprotease meprin A, has reduced bioactivity.

Authors:  Guido Boerrigter; Lisa C Costello-Boerrigter; Gail J Harty; Brenda K Huntley; Alessandro Cataliotti; Harald Lapp; John C Burnett
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-04-22       Impact factor: 3.619

9.  Effect of endopeptidase-24.11 inhibition and of atrial natriuretic peptide clearance receptor ligand on the response to rat brain natriuretic peptide in the conscious rat.

Authors:  J E Kirk; M R Wilkins
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

10.  Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent.

Authors:  Brian Casserly; James R Klinger
Journal:  Drug Des Devel Ther       Date:  2009-12-29       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.